Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19
Author(s) -
Jonathan H. Shrimp,
John Janiszewski,
Catherine Z. Chen,
Miao Xu,
Kelli M. Wilson,
Stephen C. Kales,
Philip E.J. Sanderson,
Paul Shinn,
Rick Schneider,
Zina Itkin,
Hui Guo,
Min Shen,
Carleen KlumppThomas,
Sam Michael,
Wei Zheng,
Anton Simeonov,
Matthew D. Hall
Publication year - 2022
Publication title -
acs infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.324
H-Index - 39
ISSN - 2373-8227
DOI - 10.1021/acsinfecdis.2c00172
Subject(s) - repurposing , drug repositioning , tmprss2 , approved drug , pharmacology , drug discovery , high throughput screening , drug development , virology , computational biology , drug , clinical trial , covid-19 , medicine , biology , bioinformatics , infectious disease (medical specialty) , ecology , disease , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom